Publications

1. Ranibizumab (Lucentis) for the treatment of neovascular (wet) age-related macular degeneration

   The conclusion on t=0 was that ranibizumab could be used for the treatment of minimally classic, predominantly classic and occult ...

   Report | 23-01-2012

2. Fingolimod (Gilenya) for 'relapsing-remitting multiple sclerosis’

   In a direct comparison of fingolimod with interferon beta (Avonex) in ambulatory patients with relapsing-remitting multiple ...

   Report | 23-01-2012

3. Denosumab (XGEVA) for the 'prevention of skeletal-related events in adults with bone metastases from solid tumours’

   In the treatment of bone metastases from solid tumors, the therapeutic value of s.c. denosumab is comparable with that of i.v. ...

   Report | 23-01-2012

4. Everolimus (Votubia) for the indication 'treatment of patients aged 3 years and older with subependymal giant cell astrocytoma associated with tuberous sclerosis complex

   The use of everolimus for the treatment of patients aged 3 years and older with subependymal giant cell astrocytomas (SEGA) ...

   Report | 23-01-2012

5. Background report assessing whether occipital neurostimulation for chronic cluster headache complies with established medical science and medical practice

   Occipital neurostimulation in cases of refractory chronic cluster headaches does not comply with the ‘established medical science ...

   Report | 22-11-2011

6. Transcatheter aortic valve replacement

   In the opinion of CVZ, TAVI (transcatheter aortic valve implantation) is care that complies with established medical science and ...

   Report | 26-10-2011

7. Infliximab (Remicade) for the indication 'plaque psoriasis’

   Infliximab and adalimumab, etanercept and ustekinumab are of equal therapeutic value in the treatment of adults suffering from ...

   Report | 24-10-2011

8. Infliximab (Remicade) for the indication 'colitis ulcerosa’

   For the treatment of moderate to severe cases of colitis ulcerosa, in comparison with ciclosporin, infliximab has a therapeutic ...

   Report | 24-10-2011

9. Nursing in AWBZ institutions

   The questions focus on nursing care that is necessary in connection with that medical specialist care. CVZ acknowledges that the ...

   Report | 29-09-2011

10. Sunitinib malate (Sutent) for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours

    For the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours with disease progression ...

    Report | 26-09-2011